The Webinar "Using TomoTherapy for Complex Cases of Gynecological Cervix Cancer" explains how to use the TomoTherapy radiation therapy system for treating difficult cases of gynecological cervix cancer. This webinar occurred May 26, 2016.
Statement of Purpose/Need:
Dr. Marjory Jolicoeur, chief radiation oncologist at Hôpital Charles Lemoyne, will share how they use the TomoTherapy system for treating difficult cases of gynecological cervix cancer.
• To learn the indications of extended field radiotherapy and concomitant boost for uterine cervix cancer
• To learn how to treat uterine cervix cancer with extended field radiotherapy on the TomoTherapy system
• To learn the benefits of using the TomoTherapy System for concomitant boost
• To understand the benefits of the TomoTherapy planning on sparing organs at risk
Dr. Marjory Jolicoeur, M.D.
Hôpital Charles LeMoyne
Centre Hospitalier de l’Université de Sherbrooke
Greenfield Park, QC, Canada
After completing her radiation oncology residency in 1996 at the Université de Montréal, Jolicoeur completed a fellowship specializing in brachytherapy at the Centre George-François Leclerc in Dijon, France. She then started a professorship at the Department of Radiation Oncology of the Université de Montréal, which she still holds today. In 1999 she was appointed to the planning and construction of a new radiation oncology department for the Hôpital Charles Lemoyne, of which she currently serves as chief of department.
As a brachytherapy specialist, Jolicoeur is active in the treatment of gynecological, genitourinary, breast, head and neck and soft tissue tumor. She has special research interests in the application of brachytherapy in area such as breast, genitourinary and gynecologic cancers. She is a strong promoter for the use of brachytherapy to replace the conventional mastectomy for local recurrences of breast cancer.
Today, her main focus is the development of image guided implant procedures, the precision delivery of conformal high dose rate brachytherapy and teaching brachytherapy in the radiation-oncology program and it’s gynecologic oncology fellowship program.
Accuray is a radiation oncology company that develops, manufactures and sells precise innovative treatment solutions which set the standard of care, with the aim of helping patients live longer, better lives. The company’s leading edge technologies – the CyberKnife and TomoTherapy Systems – are designed to deliver radiosurgery, stereotactic body radiation therapy (SBRT), intensity modulated radiation therapy (IMRT), image-guided radiation therapy (IGRT) and adaptive radiation therapy. Their vision: A future where the fear, pain and suffering of cancer are a thing of the past. Their mission: To develop personalized, leading-edge treatment solutions that help cancer patients live longer, better lives.